- Filed
- Apr 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Apr 11, 2025 | 11.12M sh |
| Cash And Equivalents | FY 2024 · Dec 31, 2024 | $41.62M |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 10.13M sh |
| Capex | FY 2024 · Dec 31, 2023 | $2.5M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$3.9M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $18.26M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $18.8M |
| Current Assets | FY 2024 · Dec 31, 2023 | $27.68M |
| Total Assets | FY 2024 · Dec 31, 2023 | $33.02M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$0.20 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.19 |
| Sga Expense restated | FY 2024 · Dec 31, 2023 | $8.38M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $885K |
| Net Income | FY 2024 · Dec 31, 2023 | −$1.9M |
| Operating Income restated | FY 2024 · Dec 31, 2023 | −$7.04M |
| Gross Profit restated | FY 2024 · Dec 31, 2023 | $2.23M |
| Revenue restated | FY 2024 · Dec 31, 2023 | $11.12M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | $15.15M |